LONDON, July 13, 2018 /PRNewswire/ --
Active Ingredient (API) and Finished Dose Formulation(FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages
The pharmaceutical contract manufacturing market is expected to grow at a CAGR of 6.0% in the first half of the forecast period. The API Manufacturing submarket held 66% of the market
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 230-page report you will receive 77 tables and 58 figures- all unavailable elsewhere.
The 230-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act.
• Global Pharmaceutical Contract Manufacturing Market forecasts from 2018-2028
• Submarket forecasts at world level, from 2018-2028: • Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs) and other products • Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages and other dosage types • Other applications of outsourced production - other related services
• Revenue forecasts from 2018-2028, for these regional and national markets: • The US • Canada • Japan • EU5: Germany, France, the UK, Italy and Spain • BRIC: Brazil, Russia, India, China • South Korea • Turkey • Mexico • Others
• Assessment of selected leading companies that hold major market shares in the pharmaceutical contract manufacturing industry
• Qualitative Analysis from a CMO Perspective
• Qualitative Analysis from a Client Perspective
Visiongain's study is intended for anyone requiring commercial analyses for the pharmaceutical contract manufacturing market. You find data, trends and predictions.
Buy our report today Pharmaceutical Contract Manufacturing Market 2018-2028: Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages.
To request a report overview of this report please contact Sara Peerun at email@example.com or refer to our website : https://www.visiongain.com/report/pharmaceutical-contract-manufacturing-market-2018-2028
AbbVie Actavis ADC Biotechnology Aegerion Pharmaceuticals Aenova Group Aesica Pharma Agensys Agila Specialties Ajinomoto Althea Inc Alexion Pharmaceuticals Almac Group Althea Technologies AMRI (Albany Molecular Research Inc) API Corporation (APIC) Aspen Pharmacare Astellas AstraZeneca Banner Life Sciences Banner Pharmacaps Baring Private Equity Asia Bausch & Lomb Bayer Healthcare Ben Venue Laboratories Bend Research Biogen Idec BioIndustry Association (BIA) Biotest Blackstone Group Boehringer Ingelheim Boehringer Ingelheim BioXcellence Bristol-Myers Squibb Company Bushu Pharmaceuticals Cambrex Cambridge Major Laboratories Catalent Pharma Solutions Cedarburg Hauser Cell Therapy Catapult Celldex Therapeutics Celltrion Cenexi Chemisch-Pharmazeutisches Laboratorium Ravensburg Chemtrix China FDA (CFDA) Cipla Cook Pharmica CordenPharma CTC Bio Daito Pharmaceutical Delpharm Dishman Pharmaceuticals DPx Fine Chemicals DPx Holdings B.V. Dr. Reddy's Laboratories DSP (DSM Sinochem Pharmaceuticals) Eisai Eli Lilly Esteve Quimica Euticals Evonik Degussa Famar Fareva FUJIFILM Diosynth Biotechnologies, Gallus Biopharmaceutical, LLC. G-CON GEA Pharma-Systems Genentech GlaxoSmithKline (GSK) Granules India Haupt Pharma Hexal Hospira Hospira One2One ImmunoGen Immunomedics Indian Pharmaceutical Alliance Innovent Biologics IRIX Pharmaceuticals Janssen JK Pharmaceutical Johnson & Johnson Knowledge Transfer Network (KTN) Lonza Lupin Marinopoulos Group Matrix Laboratories Medice Medichem Merck & Co. Micron Technologies Millennium Mitsui & Co Momenta Pharmaceuticals Mylan Neuland Laboratories NICE Insight NPS Pharmaceuticals Nycomed Orchid Chemicals & Pharmaceuticals Oxford Biomedica Patheon Patheon Biologics Pfizer Pharmapak Technologies Piramal Pharma Solutions Progenics Quintiles Recepta Biopharma Recipharm Redwood Bioscience Rentschler Biotechnologie Roche Royal DSM SAFC SafeBridge Samsung Bioepis Samsung BioLogics Sandoz Sanofi Seattle Genetics Shandong Xinhua ShangPharma Shire Siegfried AG Sigmar Italia SMS Pharmaceuticals Solvias AG Speedel Stada Stem CentRx Stevenage Bioscience Catalyst Takeda Temmler Group Teva API Thermo Fisher Scientific UMN Pharma UNIGEN Valeant Pharmaceuticals Valerion Therapeutics, LLC. Vetter Pharma-Fertigung GmbH Vivante GMP Solutions West Pharmaceutical Services WuXi PharmaTech Zhangjiang Biotech & Pharmaceutical Base Company Zhejiang Jiang Yuan Tang Biotechnology
To see a report overview please e-mail Sara Peerun on firstname.lastname@example.org
Subscribe to our Free Newsletters!
Polyarthritis refers to pain in four or more joints simultaneously due to various causes ranging ...
Gardner or Gardner''s syndrome, also known as familial adenomatous polyposis (FAP), is an autosomal ...
Beetroot tea is a healthy beverage, which is extremely beneficial for high blood pressure, ...View All